Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Out-of-Pocket Costs and Healthcare Utilization Related to Mastectomy vs Breast Conservation: A Claims-Based Study.

Journal of surgical oncology·2026
Same author

Optimizing Adjuvant Treatment Recommendations for Older Women with Biologically Favorable Breast Cancer: Short-Course Radiation or Long-Course Endocrine Therapy?

Current oncology (Toronto, Ont.)·2023
Same author

Restricted Access to Abortion, the Dobbs Ruling, and Radiation Oncology: Standing United Against Reproductive Injustice.

International journal of radiation oncology, biology, physics·2022
Same author

Pharmacokinetic Drug-Drug Interaction Studies Between Trilaciclib and Midazolam, Metformin, Rifampin, Itraconazole, and Topotecan in Healthy Volunteers and Patients with Extensive-Stage Small-Cell Lung Cancer.

Clinical drug investigation·2022
Same author

Postoperative Comprehensive Radiation with Curative Intent.

International journal of radiation oncology, biology, physics·2022
Same author

Early-stage Breast Cancer: Tailored External Beam Fractionation Approaches for Treatment of the Whole or Partial Breast.

Seminars in radiation oncology·2022

Related Experiment Video

Updated: May 11, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Radiotherapy after mastectomy.

Rachel C Blitzblau1, Janet K Horton

  • 1Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA. rachel.blitzblau@duke.edu

Surgical Oncology Clinics of North America
|April 30, 2013
PubMed
Summary
This summary is machine-generated.

Postmastectomy radiotherapy benefits women with node-positive or locally advanced breast cancer. Advances in cancer treatment and biology are changing how doctors decide if this radiation therapy is needed, moving beyond older prediction methods.

More Related Videos

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

Related Experiment Videos

Last Updated: May 11, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

Area of Science:

  • Oncology
  • Radiotherapy
  • Genomic Medicine

Background:

  • Historically, postmastectomy radiotherapy (PMRT) was recommended for node-positive or locally advanced breast cancer based on randomized trials.
  • Modern treatment modalities and a deeper understanding of breast cancer biology challenge these established indications.
  • Current decision-making for PMRT may not fully account for individual tumor characteristics and genomic profiles.

Purpose of the Study:

  • To explore how tumor biology and genomic medicine influence the use of postmastectomy radiotherapy.
  • To examine the shift in treatment decision-making for PMRT away from traditional TNM staging.
  • To discuss the evolving landscape of PMRT utilization in breast cancer management.

Main Methods:

  • Literature review of classic randomized trials and modern studies on breast cancer treatment.
  • Analysis of the impact of advances in surgery, systemic therapy, and radiotherapy.
  • Discussion of the role of tumor biology and genomic profiling in predicting recurrence risk.
  • Exploration of the limitations of TNM-based predictors in current practice.

Main Results:

  • Advances in systemic therapies and radiotherapy techniques have altered recurrence risks.
  • Genomic assays provide more precise information about tumor behavior and prognosis.
  • TNM staging alone is becoming insufficient for optimal PMRT decision-making.
  • Individualized treatment strategies are increasingly important.

Conclusions:

  • The utilization of postmastectomy radiotherapy is evolving due to improved understanding of breast cancer biology and genomics.
  • Treatment decisions are shifting towards personalized approaches that integrate genomic data beyond TNM staging.
  • Further research is needed to refine guidelines for PMRT in the context of precision medicine.